PhUSE FDA Blur Anonymization & risk measurement Transparency Services Data De-Identification & Anonymization Clinical Trial Transparency

Anonymization for Dummies

Share:
PhUSE FDA Video Blur Anonymization & risk measurement Transparency Services Data De-Identification & Anonymization Clinical Trial Transparency

Learn the Basics of Clinical Trial Data Anonymization for Health Agencies

In this session you will learn about the basics of document anonymization for Health Canada PRCI, EMA Policy 0070, and EU CTR. We also covered the basics of redaction versus anonymization, as well as more complex topics such as quantitative risk assessment, anonymization report authoring, and adverse event analysis.

This is a recording of a presentation Instem expert Cathal Gallagher gave at the Clinical Data Disclosure and Plain Language Summaries 2024 event, hosted by Informa Connect.

NOTE: Because of the size of the file, the video can take a couple of minutes to load!